Browse Articles
Discover research articles across all indexed journals
Long-term respiratory stability of elderly patients recovering from acute respiratory failure and invasive mechanical ventilation: a retrospective cohort study
Stretch-induced reversible self-growth of high aspect ratio microstructures scribed by femtosecond laser
Variation in the quality of opioid use disorder treatment in the Medicaid population in 2019
Background This study aimed to describe state- and urbanicity-stratified differences in three opioid use disorder (OUD) treatment metrics among Medicaid beneficiaries in 25 states that implemented Medicaid expansion under the Affordable Care Act by the end of 2014. Methods Using data from 2019, we identified Medicaid beneficiaries with OUD based on ICD-10 diagnosis codes. We then calculated the percentage of beneficiaries who met criteria for three metrics measuring OUD treatment quality, both overall and stratified by state and urbanicity type. The OUD treatment quality metrics considered were: (1) initiation of medication for opioid use disorder (MOUD) treatment, (2) engagement with OUD services, and (3) retention on MOUD treatment. Results Across states, we found that a median of 26.2% of beneficiaries initiated MOUD within 14 days of their OUD diagnosis date in the claims data. A median of 15.8% of beneficiaries engaged with OUD treatment services by initiating MOUD treatment within 14 days of their OUD diagnosis and receiving at least 2 distinct OUD-related services within 30 days of their MOUD initiation date. Among initiators, a median of 30.8% were retained on MOUD treatment for a minimum of 180 days. However, there was considerable heterogeneity in these three metrics across states; New Hampshire and West Virginia were found to have the highest overall performance out of the states considered. With respect to urbanicity, we found that rural and suburban areas had higher percentages of beneficiaries who met our three treatment quality metrics compared to urban areas. Conclusions We found notable geographic differences in opioid use disorder treatment quality in the U.S. Medicaid population.
In Situ Imaging Reveals Efficient Charge Separation in Monolayer MoS <sub>2</sub> –WS <sub>2</sub> Type-II Heterojunctions
Study on the effect of sprinkler layout parameters on dust removal in tunnel construction
Minimal N-hydroxyphthalimide-urethane bonds enable superior thermomechanical stability for covalent adaptable networks
Retraction: Anti-cancer effects of polyphenol-rich sugarcane extract
Transformation of Dewar Metallabenzenes: Valence Bond Isomerization to Metallabenzenes and Beyond
Identification and characterization of Phi1 and Phi3 bacteriophages targeting Xylella fastidiosa subsp. pauca, the causal agent of olive quick decline in Italy
Convergent evolutionary shifts in AGT targeting between mitochondria and peroxisomes across mammal transitions to herbivory
Acute healthcare utilization associated with positive SARS-CoV-2 testing or serology among people experiencing homelessness: A prospective cohort study
Background Current literature drastically underestimates SARS-CoV-2 infection among homeless populations, undermining our understanding of acute healthcare utilization following infection. We quantified acute healthcare utilization associated with robustly measured SARS-CoV-2 infection or reinfection among people experiencing homelessness. Methods In this prospective cohort study, we recruited randomly selected individuals experiencing homelessness in Toronto, Canada in summer 2021. Over one year of follow up, participants completed detailed surveys and provided biological samples to test for SARS-CoV-2 infection (RT-PCR and ELISA). Research data were linked to health administrative databases held at ICES, a health administrative data repository. Outcomes were identified using ICD-10 codes and temporal proximity to infection onset, and participants with confirmed infection were compared to participants without infection history. Results Two thirds of participants (n = 640) experienced at least one SARS-CoV-2 infection over the observation period; 25% experienced two or more infections. Prior to Omicron dominating infections, coding identified 1.55 (95% CI 1.0–2.5) hospitalizations and 4.39 (3.9–5.9) emergency department visits per 100 person-years; within 30 days of infection onset, rates were 4.07 (95% CI 2.9–5.6) and 13.69 (95% CI 11.4–16.4), respectively. Hospitalization and emergency department rates were 16.8 and 2.4 times higher than during random 30-day periods without infection. After Omicron variants became dominant, coding identified 2.27 (95% CI 1.1–4.5) hospitalizations and 3.97 (95% CI 2.4–6.7) emergency department visits per 100 person-years; within 30 days of infection, rates were 1.29 (95% CI 0.3–3.3) hospitalizations and 5.8 (95% CI 3.6–9.0) emergency department visits per 100-person years. However, post-Omicron rates within 30 days of infection were not significantly higher than for 30-day periods without infection. Conclusions Despite extremely high SARS-CoV-2 infection and reinfection rates, people experiencing homelessness in Toronto had relatively low rates of acute healthcare utilization following infection. Future work is needed to ascertain rates of chronic outcomes, like post-COVID condition.
High-Pressure Fabrication of Atomically Precise Chiral Silver Nanoclusters with High Luminescence Efficiency
Multi-scale studies of oil–water imbibition mechanism on complex pore structures and mixed-wettability: a recent 10-year review
Dolutegravir restores gut microbiota in late-stage HIV-1 unlike darunavir: an open-label, randomized clinical trial
Cost analysis of hospital-based symptomatic uterine fibroids in the kingdom of Eswatini: A prevalence-based cost-of-illness study
Background Uterine fibroids are common benign tumours of uterine smooth muscle. It has been established that uterine fibroids cause a marked global financial burden on healthcare systems and society; however, significant gaps exist in the knowledge of costs related to uterine fibroids. This study aimed to estimate costs associated with the diagnosis, care, and management of uterine fibroids in Eswatini. Methods The study employed the Cost of Illness (COI) method, a retrospective prevalence cost model. The provider’s perspective was used to estimate all identifiable direct medical costs of UFs. Data was collected from participants’ charge and claims records from the hospitals between 21 August 2021 and 21 August 2022. The study employed a bottom-up approach to estimate all patient costs related to uterine fibroids care and treatment. The costs were calculated at the 2022 price level and converted to United States dollars (USD) using private-payer prices. Results The total annual direct medical cost of uterine fibroids in Eswatini was estimated at USD 837894.60. This includes the total estimated costs of outpatient treatment and care, surgical treatment and care, and inpatient treatment and care. The key cost drivers were surgical and inpatient costs, USD 421583.18 and USD 110716.59, respectively. Conclusion The total annual cost estimation of uterine fibroids care is significantly high, with the majority of the cost related to theatre and hospitalisation charges. Understanding these financial implications can help guide healthcare policies and resource management.
The immune-modulatory potential of helminth-derived proteins in cellular models of inflammation: a systematic review with cross-study quantitative data analysis
Retraction Note: Multifunctional nanoagents for ultrasensitive imaging and photoactive killing of Gram-negative and Gram-positive bacteria
How do young children respond to the distress of others? Applying infrared thermography and behavioural analyses to examine the development of emotion contagion and empathy
Empathy is a core feature of the human social experience, underpinned by the sharing of and understanding of others’ states. However, we know relatively little about its early development. Here, we used the emerging technique of infrared thermography, combined with behavioural observations, to investigate how young children (1–3 years old) respond to others’ distress. We measured the emotional reactions – including changes in facial skin temperature and behavioural responses – of N = 30 typically developing children from British nurseries while they watched short video-vignettes of familiar and unfamiliar caregivers displaying emotional distress or neutral expressions. We hypothesised that children’s facial temperature change and behavioural responses (including facial expressions and self-directed behaviours) would be stronger to distress than to neutral stimuli. Based on the social bias of empathy, we hypothesised that responses would be stronger towards familiar individuals as compared to unfamiliar. Results confirmed that children’s thermal response at the nose bridge was stronger when observing someone in distress compared to the neutral control. Although model familiarity had only a weak effect, there was an effect of age, with younger infants showing stronger thermal responses to distress stimuli compared to older children. We found no effect on behavioural responses. We discuss implications of these results, including whether thermal-imagery may be a more sensitive measure of affective responding than behavioural measures, and the importance of using multiple methods. By combining physiological and behavioural measures, this study contributes to theoretical and methodological advances into understanding how internal affective processes map onto external measures in early childhood, shedding light on the development of empathy.